IperionX Strengthens Titanium Production and Expansion Pipeline
IperionX (ASX: IPX) has advanced its transition to continuous 24/7 operations at its Virginia facility, supporting its strategy to scale titanium production. The company is targeting an annualized capacity of around 200 tonnes of titanium powder by the end of 2026, with March output reaching approximately 4.2 tonnes, indicating early-stage ramp-up. This growth is supported by the commissioning of all HAMR™ systems and ongoing development of the next-generation GenX platform to enhance efficiency and throughput.
Operational developments also reflect meaningful progress in powder metallurgy and additive manufacturing capabilities, supporting the efficient production of intricate and high-performance titanium components. Customer engagement has increased across aerospace, defense, and industrial sectors, driven by the need for resilient domestic supply chains.
The company continues to progress its US government-backed 1,400-tonne expansion program, supported by funding commitments including US$47.1 million and additional contract opportunities. IperionX maintains a strong liquidity position, ending the quarter with US$48.2 million in cash and expecting a stable year-end balance.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
IperionX Strengthens Titanium Production and Expansion Pipeline
IperionX (ASX: IPX) has advanced its transition to continuous 24/7 operations at its Virginia facility, supporting its strategy to scale titanium production. The company is targeting an annualized capacity of around 200 tonnes of titanium powder by the end of 2026, with March output reaching approximately 4.2 tonnes, indicating early-stage ramp-up. This growth is supported by the commissioning of all HAMR™ systems and ongoing development of the next-generation GenX platform to enhance efficiency and throughput.
Operational developments also reflect meaningful progress in powder metallurgy and additive manufacturing capabilities, supporting the efficient production of intricate and high-performance titanium components. Customer engagement has increased across aerospace, defense, and industrial sectors, driven by the need for resilient domestic supply chains.
The company continues to progress its US government-backed 1,400-tonne expansion program, supported by funding commitments including US$47.1 million and additional contract opportunities. IperionX maintains a strong liquidity position, ending the quarter with US$48.2 million in cash and expecting a stable year-end balance.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au